Publication:
Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions

dc.contributor.authorsNas, Kemal; Kilic, Erkan; Cevik, Remzi; Bodur, Hatice; Ataman, Sebnem; Ayhan, Figen; Akgul, Ozgur; Akinci, Aysen; Altay, Zuhal; Capkin, Erhan; Dagli, Abdullah Zubeyir; Duruoz, Tuncay; Gurer, Gulcan; Gogus, Feride; Garip, Yesim; Kacar, Cahit; Kamanli, Ayhan; Kaptanoglu, Ece; Kaya, Taciser; Kocabas, Hilal; Ozdemirel, Erhan Ali; Ozel, Sumru; Sezer, Ilhan; Sunar, Ismihan; Yilmaz, Gurkan
dc.date.accessioned2022-04-25T00:11:24Z
dc.date.accessioned2026-01-11T10:25:25Z
dc.date.available2022-04-25T00:11:24Z
dc.date.issued2018
dc.description.abstractObjectives: This study aims to establish the first national treatment recommendations by the Turkish League Against Rheumatism (TLAR) for psoriatic arthritis (PsA) based on the current evidence. Materials and methods: A systematic literature review was performed regarding the management of PsA. The TLAR expert committee consisted of 13 rheumatologists and 12 physical medicine and rehabilitation specialists experienced in the treatment and care of patients with PsA from 22 centers. The TLAR recommendations were built on those of European League Against Rheumatism (EULAR) 2015. Levels of evidence and agreement were determined. Results: Recommendations included five overarching principles and 13 recommendations covering therapies for PsA, particularly focusing on musculoskeletal involvement. Level of agreement was greater than eight for each item. Conclusion: This is the first paper that summarizes the recommendations of TLAR as regards the treatment of PsA. We believe that this paper provides Turkish physicians dealing with PsA patients a practical guide in their routine clinical practice.
dc.identifier.doi10.5606/ArchRheumatol.2018.6946
dc.identifier.eissn1309-0283
dc.identifier.issn2148-5046
dc.identifier.pubmed30207576
dc.identifier.urihttps://hdl.handle.net/11424/263898
dc.identifier.wosWOS:000435672000002
dc.languageeng
dc.publisherTURKISH LEAGUE AGAINST RHEUMATISM
dc.relation.ispartofARCHIVES OF RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectExpert opinions
dc.subjectmanagement
dc.subjectpsoriatic arthritis
dc.subjecttreatment recommendation
dc.subjectTurkish League Against Rheumatism
dc.subjectMINIMAL DISEASE-ACTIVITY
dc.subjectRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
dc.subjectGUIDED CORTICOSTEROID INJECTION
dc.subjectMODIFYING ANTIRHEUMATIC DRUGS
dc.subjectPATIENT-REPORTED OUTCOMES
dc.subjectPLACEBO-CONTROLLED TRIAL
dc.subjectLONG-TERM TREATMENT
dc.subject2-YEAR FOLLOW-UP
dc.subjectDOUBLE-BLIND
dc.subjectANKYLOSING-SPONDYLITIS
dc.titleManagement of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage127
oaire.citation.issue2
oaire.citation.startPage108
oaire.citation.titleARCHIVES OF RHEUMATOLOGY
oaire.citation.volume33

Files